Prognostic factors of recurrence of malignant pleural effusion: what is the role of neoplasia progression?

BACKGROUND: It is known that malignant pleural effusion (MPE) recurs rapidly, in a considerable number of patients. However, some patients do not have MPE recurrence. Since MPE is associated with an average survival of 4–7 months, accurate prediction of prognosis may help recognize patients at highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrão, Fernando Conrado, de Abreu, Igor Renato Louro B., de Oliveira, Mariana Campello, Viana, Geisa Garcia, Pompa Filho, José Franklin Soares, Younes, Riad Naim, Negri, Elnara Marcia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139099/
https://www.ncbi.nlm.nih.gov/pubmed/32274148
http://dx.doi.org/10.21037/jtd.2020.01.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139099/
https://www.ncbi.nlm.nih.gov/pubmed/32274148
http://dx.doi.org/10.21037/jtd.2020.01.13

Ejemplares similares